Teleflex (TFX) Competitors

Edwards Lifesciences (NYSE:EW) and Teleflex (NYSE:TFX) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

Which has more risk & volatility, EW or TFX?

Edwards Lifesciences has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Is EW or TFX more profitable?

Edwards Lifesciences has a net margin of 24.55% compared to Teleflex's net margin of 8.76%. Edwards Lifesciences' return on equity of 22.35% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	24.55%	22.35%	16.31%
Teleflex	8.76%	14.51%	8.63%

Does the media refer more to EW or TFX?

In the previous week, Edwards Lifesciences had 3 more articles in the media than Teleflex. MarketBeat recorded 17 mentions for Edwards Lifesciences and 14 mentions for Teleflex. Teleflex's average media sentiment score of 1.00 beat Edwards Lifesciences' score of 0.44 indicating that Teleflex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	8 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Teleflex	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer EW or TFX?

Edwards Lifesciences received 806 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 71.38% of users gave Edwards Lifesciences an outperform vote while only 59.47% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
Edwards Lifesciences	Outperform Votes 1327 71.38%	Underperform Votes 532 28.62%
Teleflex	Outperform Votes 521 59.47%	Underperform Votes 355 40.53%

Which has better earnings and valuation, EW or TFX?

Edwards Lifesciences has higher revenue and earnings than Teleflex. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.20B	6.36	$1.40B	$2.32	28.23
Teleflex	$3.01B	3.75	$356.33M	$6.23	38.39

Do analysts recommend EW or TFX?

Edwards Lifesciences currently has a consensus target price of $78.23, indicating a potential upside of 19.45%. Teleflex has a consensus target price of $265.57, indicating a potential upside of 11.03%. Given Edwards Lifesciences' higher probable upside, equities research analysts clearly believe Edwards Lifesciences is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	15 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.48
Teleflex	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do institutionals and insiders believe in EW or TFX?

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Edwards Lifesciences beats Teleflex on 12 of the 19 factors compared between the two stocks.